Country: Armenia
Language: English
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
tramadol (tramadol hydrochloride), paracetamol
Denk Pharma GmbH & Co. KG
N02AJ13
tramadol (tramadol hydrochloride), paracetamol
37,5mg+ 325mg
tablets film-coated
(20/2x10/) in blister
Prescription
Registered
2022-08-22
SPECIFICATION - DENK PHARMA product name: Doloforte Denk artwork: leaflet language(s): EN, FR, PT material number: 50001264/005 storage conditions: 30°C revision of text: 09/2021 open format: 840 x 148 mm fold: 2 x pre-folded (Wickelfalz) folded format: 280 x 148 mm pharma code: 22249 paper grammar: 40 g/m 2 printing colours: PANTONE YELLOW C BLACK revision/date: 1 / 18.11.2021, RSt 2 / 23.11.2021, RSt 3 / 24.11.2021, RSt _Doloforte Denk_ Film-coated tablet – oral use Analgesic Active substances: tramadol hydrochloride + paracetamol Package leaflet: Information for the patient READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPOR- TANT INFORMATION FOR YOU. – Keep this leaflet. You may need to read it again. – If you have any further questions, ask your doc- tor or pharmacist. – This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. – If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4 . What is in this leaflet 1. WHAT DOLOFORTE DENK IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DOLOFORTE DENK 3. HOW TO TAKE DOLOFORTE DENK 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE DOLOFORTE DENK 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. What Doloforte Denk is and what it is used for Doloforte Denk is a combination of two analgesics, tramadol and paracetamol, which act together to relieve your pain. Doloforte Denk is intended for use in the treat- ment of moderate to severe pain when your doctor recommends that a combination of tramadol and paracetamol is needed. Doloforte Denk should only be taken by adults and adolescents over 12 years. 2. What you need to know before you take Doloforte Denk Do not take Doloforte Denk • if you are allergic to tramadol hydrochloride, parac- etamol or any of the other ingredients of this med- icine (listed in section 6) Read the complete document
1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Doloforte Denk 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: tramadol + paracetamol. Each film-coated tablet contains 37.5 mg tramadol hydrochloride and 325 mg paracetamol. Excipient with known effect: Each film-coated tablet contains less than 1 mmol sodium (23 mg). For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet Light-yellow, oblong, biconvex film-coated tablets. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Doloforte Denk is indicated for the symptomatic treatment of moderate to severe pain. The use of Doloforte Denk should be restricted to patients whose moderate to severe pain is considered to require a combination of tramadol and paracetamol (see also section 5.1). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY The use of Doloforte Denk should be restricted to patients whose moderate to severe pain is considered to require a combination of tramadol and paracetamol. The dose should be adjusted to intensity of pain and the sensitivity of the individual patient. The lowest effective dose for analgesia should generally be selected. The total dose of 8 tablets (equivalent to 300 mg tramadol hydrochloride and 2,600 mg paracetamol) per day should not be exceeded. The dosing interval should not be less than six hours. _ _ Adults and adolescents (12 years and older) An initial dose of 2 film-coated tablets of Doloforte Denk is recommended. Additional doses can be taken as needed, not exceeding 8 tablets (equivalent to 300 mg tramadol hydrochloride and 2,600 mg paracetamol) per day. 2 The dosing interval should not be less than six hours. Doloforte Denk should under no circumstances be administered for longer than is strictly necessary (see also section 4.4). If repeated use or long-term treatment with Doloforte Denk is required as a result of the nature and severity of the illness, then careful, regular monitoring should take place (with breaks in the treatment, where possible) Read the complete document